Quick Answer
OneMedNet Corp reported R&D Expense of $1.51 million for fiscal year 2025.
OneMedNet Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $1.51M | +3.3% |
| 2024 | $1.47M | -29.0% |
| 2023 | $2.06M | +116.8% |
| 2022 | $952.7K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $323.0K | +8.4% | -15.4% |
| June 30, 2025 | $382.0K | -0.3% | +9.8% |
| March 31, 2025 | $348.0K | -21.8% | +16.8% |
| September 30, 2024 | $298.0K | -26.4% | -22.2% |
| June 30, 2024 | $383.0K | -33.9% | -13.9% |
| March 31, 2024 | $445.0K | -23.5% | +9.9% |
| September 30, 2023 | $405.0K | — | -30.1% |
| June 30, 2023 | $579.0K | — | -0.5% |
- OneMedNet Corp showed an increase of +3.3% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2025 period, OneMedNet Corp’s r&d expense has grown by 59.0% (from $952.7 thousand to $1.51 million).
- The most recent figure is from OneMedNet Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: